COMING SOON – Efficacy and Safety of LY3209590 compared with Insulin Degludec in Participants with Type 1 Diabetes Treated with Multiple Daily Injection Therapy

In by alicia.green

Locations
Macon
Condition
Diabetes

COMING SOON – Efficacy and Safety of LY3209590 compared with Insulin Degludec in Participants with Type 1 Diabetes Treated with Multiple Daily Injection Therapy

  • Hidden
  • This field is for validation purposes and should be left unchanged.

A Phase 3, Multicenter, Randomized, Parallel-Design, Open Label Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared with Insulin Degludec in Participants with Type 1 Diabetes Treated with Multiple Daily Injection Therapy (QWINT-5)


Eligibility

Inclusion Criteria
Exclusion Criteria
Back to Current Studies